中国数字医学
中國數字醫學
중국수자의학
CHINA DIGITAL MEDICINE
2015年
5期
42-43,59
,共3页
龙远雄%马利%何丽云%闫世艳%王彬%王双连
龍遠雄%馬利%何麗雲%閆世豔%王彬%王雙連
룡원웅%마리%하려운%염세염%왕빈%왕쌍련
特发性血小板减少性紫癜%患者报告临床结局(PRO)%条目筛选
特髮性血小闆減少性紫癜%患者報告臨床結跼(PRO)%條目篩選
특발성혈소판감소성자전%환자보고림상결국(PRO)%조목사선
idiopathic thrombocytopenic purpura%patient reported outcome (PRO)%entry screening
目的:筛选特发性血小板减少性紫癜(ITP)PRO量表条目,形成适合我国ITP患者疗效评价的PRO量表。方法:采用专家评分法、因子分析法、离散程度法、克朗巴赫系数(Cronbach Alpha)法、相关系数法(包括2种),从条目的重要性大、敏感性高、独立性强、代表性好、确定性等方面进行筛选。结果:终选量表共54个条目,分为生理、心理和社会3个领域,其中生理领域包括出血、疼痛与不适、睡眠与休息三个维度,最终保留条目数为36条,心理领域保留12条,社会保留6条。结论:筛选后的量表离推广运用还有一定差距,还需在其他人群中进行信度和效度检验。
目的:篩選特髮性血小闆減少性紫癜(ITP)PRO量錶條目,形成適閤我國ITP患者療效評價的PRO量錶。方法:採用專傢評分法、因子分析法、離散程度法、剋朗巴赫繫數(Cronbach Alpha)法、相關繫數法(包括2種),從條目的重要性大、敏感性高、獨立性彊、代錶性好、確定性等方麵進行篩選。結果:終選量錶共54箇條目,分為生理、心理和社會3箇領域,其中生理領域包括齣血、疼痛與不適、睡眠與休息三箇維度,最終保留條目數為36條,心理領域保留12條,社會保留6條。結論:篩選後的量錶離推廣運用還有一定差距,還需在其他人群中進行信度和效度檢驗。
목적:사선특발성혈소판감소성자전(ITP)PRO량표조목,형성괄합아국ITP환자료효평개적PRO량표。방법:채용전가평분법、인자분석법、리산정도법、극랑파혁계수(Cronbach Alpha)법、상관계수법(포괄2충),종조목적중요성대、민감성고、독립성강、대표성호、학정성등방면진행사선。결과:종선량표공54개조목,분위생리、심리화사회3개영역,기중생리영역포괄출혈、동통여불괄、수면여휴식삼개유도,최종보류조목수위36조,심리영역보류12조,사회보류6조。결론:사선후적량표리추엄운용환유일정차거,환수재기타인군중진행신도화효도검험。
Objective:To screen PRO scale items of idiopathic thrombocytopenic purpura and form the PRO scale suitable for the evaluation of therapeutic efficiency of ITP patients in China. Methods: The expert grading method, factor analysis method, discrete degree method, Cronbach Alpha method and correlation coefficient method (including two methods) are used to screen from the important, high-sensitivity, strong-independence, representative and certain entries. Results:The ultimate scale has a total of 54 items, divided into physiological, psychological and social area. Among them, the physical area includes three dimensions, which are bleeding, pain and discomfort, and sleep and rest. There are a total of 36 final reserved entries, 12 reserved entries in the psychological area and 6 social reserved entries. Conclusion: After the screening the scale still cannot be popularized and applied. We still need to do the reliability and validity test in other groups.